FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

One of America’s oldest manufacturers says AI is creating jobs — not replacing them

EXCLUSIVE: Millions of newborns to receive special Social Security cards celebrating America’s 250th birthday

‘I Am a Ruined Man’ – Japanese World Cup Tourist Gets Trapped in Hilarious Cycle – Won’t Say No to a Gift, So Free ‘Gift’ Chips Won’t Stop Coming at Mexican Restaurant

Trump honors Village People and ‘Y.M.C.A.’ singer Victor Willis after death announcement

‘Experts’ Stumped About How Trump Proved Them Wrong on Oil Prices: ‘It’s the Weirdest Thing’

Trump faces ‘worst-case scenario’ on birthright citizenship after Supreme Court shuts door on executive, legislative fixes

Harris-backed Democrat scrubs BLM-era posts as House campaign heats up

America’s favorite beers — and the jobs tied to them — are at the center of a brewing trade fight

1,000 days after Oct. 7, Israel’s military successes come at the cost of global isolation

Florida toddler dies after father realizes child was left in SUV during daycare pickup

Thousands of beer cans spill across Connecticut highway after tractor-trailer overturns

Socialism goes west as DSA-backed challenger ousts longtime Democrat

DOJ says 11 migrants indicted in multi-state sex trafficking, drug, firearms case

Anti-Trump senator defeated by far-left rival after heated gubernatorial primary

Ex-talk show host will take on former chief advisor to Kamala Harris’ husband

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”